You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR GOLYTELY


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for GOLYTELY

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00380497 ↗ Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children Completed The Hospital for Sick Children Phase 4 2006-09-01 The purpose of this trial is to compare patient's satisfaction from Pico-Salax with the standard of care, Poly-Ethylene Glycol and electrolyte solution, for bowel cleanout before colonoscopy in children, and to compare effectiveness.
NCT00611442 ↗ Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy Completed Takeda N/A 2007-10-01 The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and size of polyps detected on examination.
NCT00611442 ↗ Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy Completed Brooke Army Medical Center N/A 2007-10-01 The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and size of polyps detected on examination.
NCT00645801 ↗ Amitiza® Plus GoLYTELY® Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation Completed Takeda Pharmaceuticals North America, Inc. Phase 4 2008-03-01 The primary objective is to compare the effectiveness and tolerance of Amitiza® (lubiprostone) plus GoLYTELY® (polyethylene glycol-electrolyte solution) versus placebo and GoLYTELY ® (polyethylene glycol-electrolyte solution) as a bowel cleansing preparation for colonoscopy.
NCT00645801 ↗ Amitiza® Plus GoLYTELY® Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation Completed Henry Ford Health System Phase 4 2008-03-01 The primary objective is to compare the effectiveness and tolerance of Amitiza® (lubiprostone) plus GoLYTELY® (polyethylene glycol-electrolyte solution) versus placebo and GoLYTELY ® (polyethylene glycol-electrolyte solution) as a bowel cleansing preparation for colonoscopy.
NCT00687830 ↗ Efficacy of Morning-only Bowel Preparation for Afternoon Colonoscopy. Completed Cleveland Clinic Florida Phase 3 2008-02-01 The study aims to study the adequacy of bowel preparation (colon cleansing) for afternoon colonoscopies. The conventional regimen of giving bowel prep on the evening prior to the day of the colonoscopy will be compared with that given on the morning of an afternoon colonoscopy. Endoscopist scoring the bowel cleansing efficacy with an Ottawa Scale are blinded to the randomization process.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for GOLYTELY

Condition Name

Condition Name for GOLYTELY
Intervention Trials
Colonoscopy 8
Bowel Preparation Before Colonoscopy 2
Bowel Preparation for Colonoscopy 2
Hepatic Encephalopathy 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for GOLYTELY
Intervention Trials
Colonic Neoplasms 2
Liver Cirrhosis 2
Hepatic Encephalopathy 2
Fibrosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for GOLYTELY

Trials by Country

Trials by Country for GOLYTELY
Location Trials
United States 22
Canada 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for GOLYTELY
Location Trials
Texas 3
California 2
New York 2
Connecticut 2
Pennsylvania 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for GOLYTELY

Clinical Trial Phase

Clinical Trial Phase for GOLYTELY
Clinical Trial Phase Trials
Phase 4 11
Phase 3 1
Phase 2 1
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for GOLYTELY
Clinical Trial Phase Trials
Completed 12
Withdrawn 3
Not yet recruiting 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GOLYTELY

Sponsor Name

Sponsor Name for GOLYTELY
Sponsor Trials
Mayo Clinic 2
Brooke Army Medical Center 2
VA Office of Research and Development 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for GOLYTELY
Sponsor Trials
Other 19
U.S. Fed 6
Industry 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.